Canada-listed cultivator of medical and recreational cannabis company Zenabis Global said Tuesday it entered into a new supply agreement with Tilray Inc .
Zenabis LTD, a wholly-owned subsidiary of Zenabis Global, said it entered into an agreement with High Park Holdings, a fully-owned subsidiary of Tilray. As part of the agreement, High Park will advance CA$30 million ($22.8 million USD) to Zenabis in return for a supply of dried cannabis.
Zenabis said it doesn't expect the new agreement to have any impact on existing customers.
Zenabis CEO Andrew Grieve said the new agreement "significantly reduces" the potential for the company to withdraw capital from its $60 million unsecured convertible debenture facility. He also said the agreement validates its ability to produce consistent and premium cannabis products.
Zenabis will deliver each month dried cannabis to High Park with the first delivery scheduled for October. The prepaid amount will vary as it is dependent on the product type and format High Park orders.
Zenabis Global's Toronto-listed stock was higher by more than 10%, while Tilray shares traded lower by 2.6% to $48 at time of publication.
在加拿大上市的医用和娱乐大麻品种公司 Zenabis Global 周二表示，该公司与 Tilray Inc .达成了一项新的供应协议。
Zenabis Global 的全资子公司 Zenabis LTD 表示，它与 Tilray 的全资子公司 High Park Holdings 签订了协议。作为协议的一部分， HighPark 将向 Zenabis 预付3000万加元（2280万美元），以换取干大麻的供应。
Zenabis 首席执行官 AndrewGrieve 说，新协议“大大降低了”该公司从其6000万美元无担保可转换债券融资中撤出资金的可能性。他还表示，该协议验证了其生产一致和优质大麻产品的能力。
Zenabis 将每月向 High Park 交付干大麻，首次交付计划于10月。预付金额将根据产品类型和高园订单格式而有所不同。
Zenabis Global 在多伦多上市的股票上涨了10%以上，而 Tilray 的股票在发行时下跌了2.6%至48美元。